TABLE 1.

Baseline characteristics of study sample (n=104)

Site of care
Site 1, n (%)	24 (23)
Site 2, n (%)	59 (57)
Site 3, n (%)	21 (20)
Female, n (%)	51 (49)
Age, median (IQR) years	12.1 (6.8-17.1)
White non-Hispanic	93 (89)
Diagnosis
Hematologic malignancy, n (%)	36 (34)
Solid tumor, n (%)	58 (56)
Brain tumor, n (%)	10 (10)
Months from diagnosis to enrollment, median (IQR)	27 (17-51)
Months from last disease progression to enrollment, median (IQR)	5.9 (3.4-9.4)
Intervention arm, n (%)	51 (49)

Abbreviations:SD, standard deviation; IQR, interquartile range